Trademark: 90492334
Word
CAYARRA
Status
Pending
Status Code
733
Status Date
Wednesday, March 13, 2024
Serial Number
90492334
Mark Type
4000
Filing Date
Wednesday, January 27, 2021
Published for Opposition
Tuesday, September 28, 2021

Trademark Owner History
Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; ; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

Trademark Events
Mar 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2024
Sou Extension 4 Granted
Mar 13, 2024
Sou Extension 4 Filed
Mar 13, 2024
Sou Teas Extension Received
Sep 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2023
Sou Extension 3 Granted
Sep 14, 2023
Sou Extension 3 Filed
Sep 14, 2023
Sou Teas Extension Received
Mar 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 9, 2023
Sou Extension 2 Granted
Mar 9, 2023
Sou Extension 2 Filed
Mar 9, 2023
Sou Teas Extension Received
Sep 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2022
Sou Extension 1 Granted
Sep 15, 2022
Sou Extension 1 Filed
Sep 15, 2022
Sou Teas Extension Received
Mar 22, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 6, 2022
Extension Of Time To Oppose Process - Terminated
Dec 21, 2021
Changes/Corrections After Pub Approval Entered
Dec 21, 2021
Assigned To Petition Staff
Dec 2, 2021
Teas Post Publication Amendment Received
Oct 28, 2021
Teas Change Of Correspondence Received
Oct 28, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2021
Extension Of Time To Oppose Received
Sep 28, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 28, 2021
Published For Opposition
Sep 8, 2021
Notification Of Notice Of Publication E-Mailed
Aug 20, 2021
Approved For Pub - Principal Register
Aug 13, 2021
Assigned To Examiner
Apr 29, 2021
New Application Office Supplied Data Entered
Jan 30, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24